Bruton’s Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
Condition(s):B-cell LymphomaLast Updated:October 11, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):B-cell LymphomaLast Updated:October 11, 2018Terminated
Condition(s):B-cell LymphomaLast Updated:October 22, 2021Completed
Condition(s):Diffuse Large B-cell Lymphoma(DLBCL)Last Updated:February 28, 2022Recruiting
Condition(s):Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Follicular Lymphoma; Richter Transformation LymphomaLast Updated:March 21, 2024Recruiting
Condition(s):Lymphoma, B-Cell; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Waldenstrom Macroglobulinemia; Mantle Cell Lymphoma; Diffuse Large B Cell Lymphoma; Richter’s Transformation; Follicular Lymphoma; Marginal Zone LymphomaLast Updated:March 8, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.